Table 2.
Gender differences in fatigue and dyspnoea symptoms in COVID-19 survivors
| Women (n = 541), n (%) | Men (n = 601), n (%) | Adjusted OR | |
|---|---|---|---|
| Fatigue (n = 695/1,142) | |||
| No (n = 447) | 174 (32) | 273 (45.5) | |
| Mild (n = 342) | 169 (31.5) | 173 (28.5) | 1.55 (95% CI: 1.16–2.06), p = 0.003* |
| Moderate (n = 258) | 143 (26.5) | 115 (19.5) | 1.98 (95% CI: 1.44–2.69), p < 0.001* |
| Severe (n = 95) | 55 (10) | 40 (6.5) | 2.12 (95% CI: 1.36–3.32), p = 0.001* |
| Dyspnoea on exercise (n = 627/1,142) | |||
| No (n = 608) | 203 (37.5) | 312 (52) | |
| Mild (n = 345) | 183 (34) | 162 (27) | 1.70 (95% CI: 1.29–2.24), p < 0.001* |
| Moderate (n = 213) | 111 (20.5) | 102 (17) | 1.65 (95% CI: 1.20–2.28), p = 0.002* |
| Severe (n = 69) | 44 (8) | 25 (4) | 2.40 (95% CI: 1.49–4.13), p < 0.001* |
| Dyspnoea at rest (n = 268/1,142) | |||
| No (n = 874) | 387 (71.5) | 487 (81.5) | |
| Mild (n = 199) | 111 (20.5) | 88 (14.5) | 1.63 (95% CI: 1.19–2.22), p = 0.002* |
| Moderate (n = 48) | 32 (6) | 16 (2.5) | 2.31 (95% CI: 1.26–4.23), p = 0.007* |
| Severe (n = 21) | 11 (2) | 10 (1.5) | 1.39 (95% CI: 0.58–3.31), p = 0.454 |
OR, odds ratio; CI, confidence interval. * Significant differences between males and females.